Efficacy and Safety of Seralutinib in Adult Subjects With Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)
Clinical trial NCT07181382 · SUSPENDED
Trial details
- NCT number
- NCT07181382
- Sponsor
- GB002, Inc.
- Status
- SUSPENDED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2026-02-01
- Primary completion
- 2028-12-01
- Enrollment
- 480
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.